Correlation between serum matrix metalloproteinase 2 and metabolic syndrome
- Author:
- No author available
- Journal Title:
- Chinese Journal of Biomedical Engineering
- Issue:
- 3
- DOI:
- 10.3760/cma.j.issn.1674-1927.2012.03.015
- Key Word:
- 基质金属蛋白酶2;代谢综合征;细胞外基质;流行病学研究;Matrix metalloproteiuase 2;Metabolic syndrome;Extracellular matrix;Epidemiologie studies
Abstract： Objective To compare serum matrix metalloproteinase 2 (MMP-2) levels in patients with metabolic syndrome (MS) and healthy controls,and to determine the correlation between MMP-2 and components and risk factors of MS.Methods An epidemiologic survey was undertaken in Longfeng and Sushe communities,Haizhu district,Guangzhou,between July 2009 and October 2009,and 75 patients with MS and 82 heahhy controls were screened.Serum MMP-2 levels were detected via enzyme-linked immunosorbent assay (ELISA),and the correlation with each disease components and risk factors in patients with MS were analyzed.Results Patients with MS yielded considerably lower serum MMP-2 level than controls [ (216.6±51.6) μg/L vs (232.9±49.8) μg/L,P＜0.05].In MS patients,serum MMP-2 level was negatively correlated with triglycerol(TG),body mass index (BMI),waist circumference(WC) and diastolic blood pressure ( DBP ) ( r=-0.217,-0.188,-0.191 and -0.199,respectively,all P＜0.05 ),but was positively correlated with age (r=0.263,P＜0.05).Conclusion Reduced serum MMP-2 level may be responsible for the pathologenesis of extracellular matrix condensation in the cardiovascular system in patients with MS.
- [1]中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].2004,(3).
- [2]张丽芳,柯元南.大鼠动脉内膜损伤后血管重塑相关因子的动态变化[J].2007,(2).
- [3]Wolf BM,Ferran LJ Jr,Tanji N,etc.Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model.[J].2001,107(6).
- [4]Newby AC.Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.[J].2005,85(1).
- [5]Isomaa B,Taskinen MR,Tuomi T,etc.Cardiovascular morbidity and mortality associated with the metabolic syndrome.[J].2001,24(4).
- [6]Miksztowicz V,Royer M,Muzzio ML.Increased plasma activity of metalloproteinase 2 in women with metabolic syndrome.[J].2008,57(11).
- [7]Derosa G,Manca M,Gaddi AV,etc.Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease.[J].2007,14(4).
- [8]Courbon D,Gariepy J,Tzourio C,etc.The metabolic syndrome and the carotid artery structure in noninstitutionalized elderly subjects: the three-city study.[J].2007,38(3).
- [9]Marcaccini AM,Gerlach RF,Goncalves FM,etc.Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.[J].2009,403(1).